News
STOP's monthly newsletter is packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations. The opening Letter from the Director is posted
Recent Letters from the Director
Employer Insurance Coverage of Obesity Treatment
Employer Insurance Coverage of Obesity Treatment
May 29, 2025
Limitations in access and coverage of obesity medications has paralleled the advances in the usage of GLP-1s.
Guest Letter: Concerns About Compounded GLP-1 Medications
Concerns About Compounded GLP-1 Medications
April 29, 2025
OAC has long advised our members against using compounded GLP-1’s. The main reason is FDA’s own words about compounding.
FDA's New Draft Guidance for Obesity Medications
FDA's New Draft Guidance for Obesity Medications
March 31, 2025
This past January the FDA published a draft guidance entitled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.”
Read Past Letters from the Director
